+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Testosterone Replacement Therapy Market by Indication, Product Type, Drug Active Ingredient, Distribution Channel, End-Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666355
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Testosterone Replacement Therapy Market grew from USD 519.08 million in 2023 to USD 557.32 million in 2024. It is expected to continue growing at a CAGR of 7.85%, reaching USD 881.19 million by 2030.

Testosterone Replacement Therapy (TRT) is utilized primarily to treat individuals with conditions leading to low testosterone levels, such as hypogonadism. This therapy aims to improve symptoms like fatigue, muscle loss, and libido decline in affected individuals. The necessity of TRT revolves around its ability to enhance quality of life for men experiencing testosterone deficiencies, positively impacting mental health, energy levels, and overall well-being. TRT is applied via several methods, including injections, transdermal patches, gels, and oral medications, catering to diverse patient preferences and medical needs. End users primarily comprise older men, athletes, individuals with muscle-wasting diseases, and transgender men. Market growth for TRT is being driven by increasing awareness of hypogonadism, the aging global population, and rising healthcare investments. Moreover, technological advancements in formulation and delivery systems are expanding the treatment's efficacy and patient adherence. Opportunities lie in targeting unmet needs in developing regions, the personalization of therapies, and leveraging digital platforms for awareness and education. Challenges, however, include regulatory hurdles, potential side effects of long-term use, stigma, and competition from alternative therapies like natural test boosters. Legal restrictions in sports on using TRT are also notable barriers. The best areas for innovation and research include developing safer, more efficient delivery systems, implementing AI for personalized medicine, and expanding clinical studies into broader demographic categories. Insights into the market indicate it is highly competitive and fragmented, characterized by the presence of both established pharmaceutical giants and smaller biotechnology firms. For businesses aiming to grow, strategic partnerships, regulatory compliance, and patient-focused innovation are paramount. Companies should also focus on robust R&D to mitigate side effects and improve therapeutic outcomes, thereby enhancing market share and patient satisfaction.

Understanding Market Dynamics in the Testosterone Replacement Therapy Market

The Testosterone Replacement Therapy Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing prevalence of testosterone deficiency
    • Rising awareness of treatment of testosterone deficiency and erectile dysfunction.
    • High adoption for non-medical uses such as body-building and enhancing sexual performance
  • Market Restraints
    • High cost of testosterone replacement therapy
  • Market Opportunities
    • Increased clinical research and development for novel products
    • Government initiatives and availability of drugs through online & offline pharmacies
  • Market Challenges
    • Complications associated with the testosterone replacement therapy

Exploring Porter’s Five Forces for the Testosterone Replacement Therapy Market

Porter’s Five Forces framework further strengthens the insights of the Testosterone Replacement Therapy Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Testosterone Replacement Therapy Market

External macro-environmental factors deeply influence the performance of the Testosterone Replacement Therapy Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Testosterone Replacement Therapy Market

The Testosterone Replacement Therapy Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Testosterone Replacement Therapy Market

The Testosterone Replacement Therapy Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Testosterone Replacement Therapy Market

The Testosterone Replacement Therapy Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Testosterone Replacement Therapy Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc, Acerus Pharmaceuticals Corp, Acrux Ltd., Actiza Pharmaceutical Pvt. Ltd., Antares Pharma Inc., Aytu BioPharma Inc., Bausch Health Co. Inc, Bayer AG, Cipla Ltd., Clarus Therapeutics Inc.,, Eli Lilly and Co., Endo International Plc, Novartis AG,, Pfizer Inc., and Sun Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Testosterone Replacement Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Indication
    • Autoimmune Conditions
    • Genetic Disorders
    • Hypogonadism
    • Sex Organ Surgeries
  • Product Type
    • Buccal Adhesive
    • Gel or Creams
    • Implants
    • Oral
    • Parenteral
    • Patches
  • Drug Active Ingredient
    • Methyltestosterone
    • Testosterone Cypionate
    • Testosterone Enanthate
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy & Retail Pharmacy
  • End-Users
    • Homecare
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of testosterone deficiency
5.1.1.2. Rising awareness of treatment of testosterone deficiency and erectile dysfunction.
5.1.1.3. High adoption for non-medical uses such as body-building and enhancing sexual performance
5.1.2. Restraints
5.1.2.1. High cost of testosterone replacement therapy
5.1.3. Opportunities
5.1.3.1. Increased clinical research and development for novel products
5.1.3.2. Government initiatives and availability of drugs through online & offline pharmacies
5.1.4. Challenges
5.1.4.1. Complications associated with the testosterone replacement therapy
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Testosterone Replacement Therapy Market, by Indication
6.1. Introduction
6.2. Autoimmune Conditions
6.3. Genetic Disorders
6.4. Hypogonadism
6.5. Sex Organ Surgeries
7. Testosterone Replacement Therapy Market, by Product Type
7.1. Introduction
7.2. Buccal Adhesive
7.3. Gel or Creams
7.4. Implants
7.5. Oral
7.6. Parenteral
7.7. Patches
8. Testosterone Replacement Therapy Market, by Drug Active Ingredient
8.1. Introduction
8.2. Methyltestosterone
8.3. Testosterone Cypionate
8.4. Testosterone Enanthate
9. Testosterone Replacement Therapy Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy & Retail Pharmacy
10. Testosterone Replacement Therapy Market, by End-Users
10.1. Introduction
10.2. Homecare
10.3. Hospitals
10.4. Specialty Clinics
11. Americas Testosterone Replacement Therapy Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Testosterone Replacement Therapy Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Testosterone Replacement Therapy Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. TESTOSTERONE REPLACEMENT THERAPY MARKET RESEARCH PROCESS
FIGURE 2. TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 7. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2023 VS 2030 (%)
FIGURE 11. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 15. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. TESTOSTERONE REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. TESTOSTERONE REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. TESTOSTERONE REPLACEMENT THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. TESTOSTERONE REPLACEMENT THERAPY MARKET DYNAMICS
TABLE 7. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY AUTOIMMUNE CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY SEX ORGAN SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY BUCCAL ADHESIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY GEL OR CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY METHYLTESTOSTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE CYPIONATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE ENANTHATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY ONLINE PHARMACY & RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 46. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 47. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 49. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 51. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 54. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 73. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 76. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 78. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 81. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 88. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 91. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 118. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 121. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 137. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 139. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 142. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 144. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 147. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 149. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 152. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 154. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 157. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 164. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 165. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 167. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 179. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 180. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 182. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 184. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 185. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 187. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 189. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 190. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 192. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 209. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 210. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 212. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 224. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 225. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 227. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 239. TESTOSTERONE REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 240. TESTOSTERONE REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Testosterone Replacement Therapy Market, which are profiled in this report, include:
  • AbbVie Inc
  • Acerus Pharmaceuticals Corp
  • Acrux Ltd.
  • Actiza Pharmaceutical Pvt. Ltd.
  • Antares Pharma Inc.
  • Aytu BioPharma Inc.
  • Bausch Health Co. Inc
  • Bayer AG
  • Cipla Ltd.
  • Clarus Therapeutics Inc.,
  • Eli Lilly and Co.
  • Endo International Plc
  • Novartis AG,
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information